CDKN2A/B deletions including tumor suppressor genes INK4A, INK4B, and/or ARF commonly occur in all types of lymphoid malignancies and account for approximately 55 % of adult T-ALL and 30 % of BCP-ALL [3]. Here, CDKN2B is linked to acute lymphoblastic leukemia.